← All companies

BLRX

BioLineRx Ltd.

BLRX Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.66

-0.16 -5.78%

Key statistics

from XBRL data in SEC filings

Market cap

$6.94B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$2.15 – $4.56

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 8, 2026 6-K May 27, 2026 6-K May 22, 2026 6-K May 19, 2026 6-K Apr 28, 2026 20-F/A 20F/A Mar 27, 2026 6-K Mar 26, 2026 6-K Mar 23, 2026 20-F Mar 23, 2026 6-K Feb 23, 2026 6-K Nov 24, 2025 6-K Nov 17, 2025 6-K Sep 29, 2025 6-K Aug 14, 2025 6-K Jun 30, 2025 6-K May 30, 2025 6-K May 27, 2025 6-K May 23, 2025 6-K Mar 31, 2025 20-F Mar 31, 2025 6-K Jan 21, 2025 6-K Jan 17, 2025 6-K Jan 7, 2025 6-K Jan 6, 2025 6-K Nov 25, 2024 6-K Nov 21, 2024 6-K Nov 12, 2024 6-K Nov 5, 2024 6-K Oct 16, 2024 6-K Oct 1, 2024 6-K Aug 19, 2024 6-K Aug 15, 2024 6-K Jun 18, 2024 6-K May 30, 2024 6-K May 28, 2024 6-K May 24, 2024 6-K May 17, 2024 6-K May 6, 2024 6-K Apr 17, 2024 6-K Apr 10, 2024